BridgePoint Medical Closes on $9.1M
BridgePoint Medical Inc., a developer of medical technology for coronary disease, has closed on $9.1 million. An unnamed strategic investor led the round, which included participation from existing shareholders including New Enterprise Associates, Polaris Venture Partners and Foundation Medical Partners. The Series C round will help the company bolster sales and marketing of its technology.
14 March 2011•3 mins read
